AmCad BioMed Corporation
AmCad BioMed Corporation
Website
HQ Country
Taiwan
Profile
The company's devices are designed to enable early detection and diagnosis of various diseases, such as thyroid cancers, fatty liver, liver fibrosis and obstructive sleep apnea. The softwares developed by AmCad BioMed enable rapid analysis of ultrasound scan images.
Filtered by:
AmCad BioMed Corporation
Company
Topic
Show
2024
19 Jan 2024
Digital Health and Artificial Intelligence 2024-2034: Trends, Opportunities, and Outlook
IDTechEx Report:
2020
1 Apr 2020
AmCad BioMed
AmCad BioMed's devices are designed to enable early detection and diagnosis of various diseases, such as thyroid cancers, fatty liver, liver fibrosis and obstructive sleep apnea. The softwares developed by AmCad BioMed enable rapid analysis of ultrasound scan images.
Included are:
28 Feb 2020
AmCad BioMed
IDTechEx interviewed AmCad BioMed, a Taiwan-based company that developed a robotic platform for the rapid detection of obstructive sleep apnoea (OSA). OSA is vastly undiagnosed, with reports saying up to 85% of people with the condition are not aware they have it.
